The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106464263 10646426 3 F 1999 20160927 20141211 20160930 EXP US-PFIZER INC-2014335542 PFIZER 62.00 YR F Y 53.00000 KG 20160930 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106464263 10646426 1 PS LYRICA PREGABALIN 1 Oral 75 MG, 4X/DAY D V131505 21446 75 MG CAPSULE, HARD QID
106464263 10646426 2 SS LYRICA PREGABALIN 1 75 MG, 4X/DAY D 13637972 21446 75 MG CAPSULE, HARD QID
106464263 10646426 3 SS LYRICA PREGABALIN 1 75 MG, 2X/DAY (ONE IN DAY AND ONE AT NIGHT) D 21446 75 MG CAPSULE, HARD BID
106464263 10646426 4 SS LYRICA PREGABALIN 1 1 DF, 2X/DAY (ONE IN DAY AND ONE AT NIGHT) D 21446 1 DF CAPSULE, HARD BID
106464263 10646426 5 C METFORMIN METFORMIN HYDROCHLORIDE 1 1000 MG, 2X/DAY 0 1000 MG TABLET BID
106464263 10646426 6 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 500 MG, 2X/DAY 0 500 MG TABLET BID
106464263 10646426 7 C METFORMIN METFORMIN HYDROCHLORIDE 1 1000 MG, 2X/DAY 0 1000 MG TABLET BID
106464263 10646426 8 C SIMVASTATIN. SIMVASTATIN 1 Oral 80 MG, 1X/DAY 0 80 MG TABLET QD
106464263 10646426 9 C LISINOPRIL. LISINOPRIL 1 Oral 2.5 MG, DAILY 0 2.5 MG
106464263 10646426 10 C LISINOPRIL. LISINOPRIL 1 5 MG, UNK 0 5 MG
106464263 10646426 11 C LANTUS INSULIN GLARGINE 1 40 IU, DAILY 0 40 IU INJECTION
106464263 10646426 12 C TYLENOL ACETAMINOPHEN 1 UNK, AS NEEDED 0
106464263 10646426 13 C SALBUTAMOL ALBUTEROL 1 Respiratory (inhalation) UNK, AS NEEDED 0
106464263 10646426 14 C PLAVIX CLOPIDOGREL BISULFATE 1 75 MG, DAILY 0 75 MG
106464263 10646426 15 C METOPROLOL. METOPROLOL 1 25 MG, 1X/DAY 0 25 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106464263 10646426 1 Fibromyalgia
106464263 10646426 2 Neuropathy peripheral
106464263 10646426 5 Diabetes mellitus
106464263 10646426 8 Blood cholesterol increased
106464263 10646426 9 Prophylaxis
106464263 10646426 10 Blood pressure management
106464263 10646426 12 Headache
106464263 10646426 15 Blood pressure management

Outcome of event

Event ID CASEID OUTC COD
106464263 10646426 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106464263 10646426 Abdominal discomfort
106464263 10646426 Cataract
106464263 10646426 Condition aggravated
106464263 10646426 Fatigue
106464263 10646426 Impaired gastric emptying
106464263 10646426 Insomnia
106464263 10646426 Neuralgia
106464263 10646426 Nodule
106464263 10646426 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106464263 10646426 2 2012 2014 0
106464263 10646426 5 1999 0
106464263 10646426 8 1999 0
106464263 10646426 9 1999 0
106464263 10646426 11 2008 201411 0
106464263 10646426 12 2006 0
106464263 10646426 13 2000 0
106464263 10646426 14 2008 0